Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. Despite good responses to standard of care frontline chemoimmunotherapy, the prognosis of relapsed/refractory (R/R) patients remains obscured by the possible inadequate responses to salvage therapy, eligibi...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAABRON PRESS
2021-03-01
|
| Serie: | Clinical Hematology International |
| Soggetti: | |
| Accesso online: | https://www.atlantis-press.com/article/125953899/view |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|